Editorial: Breaking down barriers: Improving outcomes for teenagers and young adults with germ cell tumours

Oncology Reviews

Volumn 3, Issue 4, 2009, Pages 201-206

  Murray, Matthew J ^a,e,f   Fern, Lorna A ^b   Stark, Daniel P ^c,f   Eden, Tim O ^d   Nicholson, James C ^e,f  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d Young Oncology Unit   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f Children's Cancer and Leukaemia Group (CCLG) GCT Working Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; ETOPOSIDE DERIVATIVE; IFOSFAMIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BONE MARROW SUPPRESSION; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CONSENSUS DEVELOPMENT; DRUG SUBSTITUTION; EDITORIAL; GERM CELL TUMOR; HUMAN; LUNG TOXICITY; NEPHROTOXICITY; OTOTOXICITY; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; SUBFERTILITY; TESTIS CANCER;

EID: 70450270666     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-009-0030-7     Document Type: Editorial

References (36)

1. A Bleyer R Barr B Hayes-Lattin D Thomas C Ellis B Anderson 2008 The distinctive biology of cancer in adolescents and young adults Nat Rev Cancer 8 288 298 10.1038/nrc2349 1:CAS:528:DC%2BD1cXjsFCmsLo%3D 18354417
2. A Bleyer M Montello T Budd S Saxman 2005 National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation Cancer 103 1891 1897 10.1002/cncr.20995 15795902 (Pubitemid 40563262)
3. WA Bleyer 2002 Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials Med Pediatr Oncol 38 1 10 10.1002/mpo.1257 11835231 (Pubitemid 34037707)
4. L Fern S Davies T Eden R Feltbower R Grant M Hawkins, et al. 2008 Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group Br J Cancer 99 1967 1974 10.1038/sj.bjc.6604751 1:STN:280:DC%2BD1M%2Fit1GqtA%3D%3D 19034273
5. CV Fernandez RD Barr 2006 Adolescents and young adults with cancer: an orphaned population Paediatr Child Health 11 103 106 19030262
6. A Ferrari A Bleyer 2007 Participation of adolescents with cancer in clinical trials Cancer Treat Rev 33 603 608 10.1016/j.ctrv.2006.11.005 17250970 (Pubitemid 350047371)
7. JS Whelan LA Fern 2008 Poor accrual of teenagers and young adults into clinical trials in the UK Lancet Oncol 9 306 307 10.1016/S1470-2045(08)70080-9 18374282
8. ME Burke K Albritton N Marina 2007 Challenges in the recruitment of adolescents and young adults to cancer clinical trials Cancer 110 2385 2393 10.1002/cncr.23060 17918260 (Pubitemid 350174923)
9. A Ferrari M Montello T Budd A Bleyer 2008 The challenges of clinical trials for adolescents and young adults with cancer Pediatr Blood Cancer 50 1101 1104 10.1002/pbc.21459 18360838
10. H Hallbook G Gustafsson B Smedmyr S Soderhall M Heyman 2006 Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol Cancer 107 1551 1561 10.1002/cncr.22189 16955505 (Pubitemid 44546916)
11. G Teilum 1965 Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary Acta Pathol Microbiol Scand 64 407 429 1:STN:280:DyaF28%2FgvVOmsg%3D%3D 5318716
12. Cancer Research UK (CRUK) (2009) Testicular cancer incidence statistics. http://info.cancerresearchuk.org/cancerstats/types/testis/incidence/#age.q Accessed 9 Oct 2009
13. JM Birch RD Alston AM Kelsey MJ Quinn P Babb RJ McNally 2002 Classification and incidence of cancers in adolescents and young adults in England 1979-1997 Br J Cancer 87 1267 1274 10.1038/sj.bjc.6600647 1:STN:280:DC%2BD38nnslKrtg%3D%3D 12439716 (Pubitemid 36009132)
14. RD Alston M Geraci TO Eden A Moran S Rowan JM Birch 2008 Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979-2003 Cancer 113 2807 2815 10.1002/cncr.23901 18846564
15. Office of National Statistics (ONS) Cancer statistics registrations (2008) http://www.statistics.gov.uk/downloads/theme-health/MB1-37/MB1-37-2006. pdf. Accessed 9 Oct 2009
16. International Germ Cell Cancer Collaborative Group 1997 International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers J Clin Oncol 15 594 603
17. JR Mann F Raafat K Robinson J Imeson P Gornall M Sokal, et al. 2000 The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity J Clin Oncol 18 3809 3818 1:CAS:528:DC%2BD3cXos1Orsbs%3D 11078494
18. AL Frazier P Rumcheva T Olson R Giller B Cushing J Cullen, et al. 2008 Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group Pediatr Blood Cancer 50 746 751 10.1002/pbc.21304 18085675 (Pubitemid 351354777)
19. S Krege J Beyer R Souchon P Albers W Albrecht F Algaba, et al. 2008 European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I Eur Urol 53 478 496 10.1016/j.eururo.2007.12.024 18191324
20. S Krege J Beyer R Souchon P Albers W Albrecht F Algaba, et al. 2008 European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II Eur Urol 53 497 513 10.1016/j.eururo.2007.12.025 18191015
21. JW Stern N Bunin 2002 Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors Med Pediatr Oncol 39 163 167 10.1002/mpo.10134 12210444 (Pubitemid 34827564)
22. R de Wit K Fizazi 2006 Controversies in the management of clinical stage I testis cancer J Clin Oncol 24 5482 5492 10.1200/JCO.2006.07.9434 17158533 (Pubitemid 46631328)
23. GV Kondagunta RJ Motzer 2006 Chemotherapy for advanced germ cell tumors J Clin Oncol 24 5493 5502 10.1200/JCO.2006.08.7882 1:CAS:528: DC%2BD2sXmvVSrug%3D%3D 17158534 (Pubitemid 46631329)
24. A Horwich DT Sleijfer SD Fossa SB Kaye RT Oliver MH Cullen, et al. 1997 Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial J Clin Oncol 15 1844 1852 1:CAS:528:DyaK2sXjsVCls7c%3D 9164194
25. R de Wit G Stoter SB Kaye DT Sleijfer WG Jones WW ten Bokkel Huinink, et al. 1997 Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group J Clin Oncol 15 1837 1843 9164193
26. JM O'Sullivan RA Huddart AR Norman J Nicholls DP Dearnaley A Horwich 2003 Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours Ann Oncol 14 91 96 10.1093/annonc/mdg020 12488299 (Pubitemid 36150265)
27. PC Rogers TA Olson JW Cullen DF Billmire N Marina F Rescorla, et al. 2004 Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study-Pediatric Oncology Group 9048 and Children's Cancer Group 8891 J Clin Oncol 22 3563 3569 10.1200/JCO.2004.01.006 15337806 (Pubitemid 41103663)
28. CR Nichols PJ Catalano ED Crawford NJ Vogelzang LH Einhorn PJ Loehrer 1998 Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study J Clin Oncol 16 1287 1293 1:CAS:528:DyaK1cXis1GhsLo%3D 9552027
29. JM Ribera A Oriol MA Sanz M Tormo P Fernandez-Abellan E del Potro, et al. 2008 Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96 J Clin Oncol 26 1843 1849 10.1200/JCO.2007.13.7265 1:CAS:528:DC%2BD1cXmsFemtr4%3D 18398150
30. G Tscherry E Jacky LM Jost RA Stahel 2000 Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study Oncology 59 110 117 10.1159/000012146 1:CAS:528:DC%2BD3cXmvFyitrw%3D 10971168
31. MK Fritsch DT Schneider AE Schuster FE Murdoch EJ Perlman 2006 Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors Pediatr Dev Pathol 9 115 131 10.2350/08-05-0097.1 1:CAS:528:DC%2BD28XntF2jsbY%3D 16822086 (Pubitemid 44049395)
32. RD Palmer NL Barbosa-Morais EL Gooding B Muralidhar CM Thornton MR Pett, et al. 2008 Pediatric malignant germ cell tumors show characteristic transcriptome profiles Cancer Res 68 4239 4247 10.1158/0008-5472.CAN-07-5560 1:CAS:528:DC%2BD1cXmsFKmtbg%3D 18519683
33. RD Palmer NA Foster SL Vowler I Roberts CM Thornton JP Hale, et al. 2007 Malignant germ cell tumours of childhood: new associations of genomic imbalance Br J Cancer 96 667 676 10.1038/sj.bjc.6603602 1:CAS:528:DC%2BD2sXhvV2jt78%3D 17285132 (Pubitemid 46303540)
34. DT Schneider AE Schuster MK Fritsch G Calaminus D Harms U Gobel, et al. 2001 Genetic analysis of childhood germ cell tumors with comparative genomic hybridization Klin Padiatr 213 204 211 10.1055/s-2001-16852 1:STN:280: DC%2BD3MrhvVSrtA%3D%3D 11528555 (Pubitemid 32801573)
35. Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin LX, Patil S et al (2009) Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol. doi: 10.1200/JCO.2008.20.0386
36. S Mueller M Schittenhelm F Honecker E Malenke K Lauber S Wesselborg, et al. 2006 Cell-cycle progression and response of germ cell tumors to cisplatin in vitro Int J Oncol 29 471 479 1:CAS:528:DC%2BD28XotFKlsL4%3D 16820891